Get the Stockscreener App
14.45
1.55%
0.22
Inmode Ltd stock is traded at $14.45, with a volume of 1.35M.
It is up +1.55% in the last 24 hours and down -6.53% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
See More
Previous Close:
$14.23
Open:
$14.5
24h Volume:
1.35M
Relative Volume:
0.98
Market Cap:
$887.59M
Revenue:
$492.05M
Net Income/Loss:
$197.92M
P/E Ratio:
6.2826
EPS:
2.3
Net Cash Flow:
$176.12M
1W Performance:
-0.82%
1M Performance:
-6.53%
6M Performance:
-25.55%
1Y Performance:
-21.30%
1-Day Range:
$14.34
$14.78
1-Week Range:
$14.01
$14.82
52-Week Range:
$13.68
$19.85
Inmode Ltd Stock (INMD) Company Profile
Compare INMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.45 | 887.59M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
DOMA Perpetual urges InMode to replace CEO, resume buybacks - Investing.com
DOMA Perpetual urges InMode to replace CEO, resume buybacks By Investing.com - Investing.com India
InMode (INMD) Urged by Major Shareholder to Revamp Leadership an - GuruFocus
Shareholders that lost money on InMode Ltd. (INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
InMode Shareholder DOMA Perpetual Seeks CEO Ouster, Buyback Resumption - marketscreener.com
Doma Perpetual Sends Letter To The Board Of Inmode To Resume Share Repurchase Program - marketscreener.com
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program - PR Newswire
Shareholders that lost money on InMode Ltd.(INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indo-Asian News Service - Indo-Asian News Service (IANS)
InMode Ltd. has secured a significant legal victory against counterfeit sellers of its Morpheus8 devices, reinforcing its commitment to consumer safety and intellectual property protection. - medianet.com.au
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode to Present at Upcoming Investor Conferences and Events - Stock Titan
InMode (INMD) Wins Legal Battle Against Counterfeit Sellers - GuruFocus
We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings - Yahoo Finance
InMode Granted Injunction Against Counterfeit Sellers of Morpheus8 Products - marketscreener.com
InMode (INMD) Secures Legal Victory Against Counterfeiters | INM - GuruFocus
InMode wins court case against counterfeit sellers - Investing.com Australia
InMode wins court case against counterfeit sellers By Investing.com - Investing.com South Africa
Court Orders Shutdown of Counterfeit Morpheus8 Sellers: How to Verify Your Provider's Authenticity - Stock Titan
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M - Seeking Alpha
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth - Seeking Alpha
(INMD) Trading Signals - news.stocktradersdaily.com
Canaccord cuts InMode stock target to $15, maintains hold rating By Investing.com - Investing.com South Africa
InMode Ltd. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
InMode Reports Q1 2025 Financial Results Amid Challenges - TipRanks
Canaccord cuts InMode stock target to $15, maintains hold rating - Investing.com
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concern - GuruFocus
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concerns | INMD Stock News - GuruFocus
UBS Adjusts InMode Price Target to $16.25 From $19, Maintains Neutral Rating - marketscreener.com
InMode (INMD) Price Target Reduced by UBS Amid Uncertain Near-Te - GuruFocus
BTIG cuts InMode stock rating amid challenging market By Investing.com - Investing.com Nigeria
BTIG cuts InMode stock rating amid challenging market - Investing.com
InMode Ltd. (NASDAQ:INMD) Q1 2025 Earnings Call Transcript - Insider Monkey
InMode (INMD) Price Target Reduced Amid Ongoing Challenges | INM - GuruFocus
BTIG Research Downgrades InMode to Neutral From Buy - marketscreener.com
InMode (INMD) Price Target Reduced Amid Ongoing Challenges | INMD Stock News - GuruFocus
InMode (INMD) Faces Downgrade Amid Challenging Market Conditions - GuruFocus
InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (NASDAQ:INMD) - Seeking Alpha
InMode Shares Dip Over 11% After Earnings Miss Expectations - Finimize
InMode (INMD) Revises Profit Guidance Amid Economic Hurdles - GuruFocus
InMode revenue decreases 3% to USD 77.9 million in Q1 2025 - Medical Buyer
InMode Ltd (INMD) Shares Gap Down to $14.355 on Apr 28 - GuruFocus
InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) - Seeking Alpha
InMode slides on lowered full year profit guidance - MSN
INMD Beats Revenue Expectations, Faces U.S. Market Challenges | - GuruFocus
Baird Downgrades InMode to Neutral From Outperform, $16 Price Target; Shares Fall - marketscreener.com
InMode slides on full year profit guidance cut (INMD:NASDAQ) - Seeking Alpha
InMode: Q1 Earnings Snapshot - The Wilton Bulletin
InMode earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):